Low-dose aspirin is commonly used to prevent heart attacks and strokes, especially in people at risk for cardiovascular disease. However, recent research shows that daily low-dose aspirin use in older adults may increase the risk of developing anemia by about 20% 1. Anemia in older adults is linked to fatigue, disability, and higher mortality, making this a significant concern for healthy seniors considering aspirin therapy2 1.
Anemia Risk from Internal Bleeding
Anemia occurs when the body has fewer red blood cells or less hemoglobin than normal, leading to symptoms such as fatigue, weakness, and dizziness. In older adults, anemia is often caused by iron deficiency, which can result from chronic internal bleeding, particularly in the gastrointestinal (GI) tract3 . Low-dose aspirin, typically 75 to 100 mg daily, is known to increase the risk of bleeding by interfering with platelet function and damaging the protective lining of the GI tract4 5.
The ASPREE trial, a large, double-blind, placebo-controlled study, enrolled 19,114 healthy community-dwelling older adults aged 70 years and above (65 years for U.S. minorities) without overt cardiovascular disease or physical disability6 7. Participants were randomized to receive 100 mg of aspirin daily or placebo and followed for a median of 4.7 years6 7. The trial found that those taking aspirin had a 20% higher incidence of anemia compared to placebo, with a hazard ratio of 1.20 (95% CI 1.12–1.29) 6.
Similarly, a Danish register-based cohort study involving 313,508 older adults reported that 5.9% of aspirin users developed anemia, compared to a lower rate in non-users8 . Severe anemia was more common in aspirin users (1.3%) than in non-users (0.6%) 8. About one in five individuals with anemia also experienced bleeding, suggesting that occult (hidden) blood loss, mainly from the GI tract, is a key mechanism behind aspirin-associated anemia8 3.
Taking aspirin every day can lower the risk of heart attack and stroke but is not suitable for everyone. Older adults should discuss with their doctors whether aspirin is appropriate and consider alternatives like clopidogrel or lifestyle changes11 5.
In the ASPREE trial, aspirin users showed a greater decline in hemoglobin and ferritin levels—markers of anemia and iron stores—than placebo users8 9. This decline was independent of major bleeding events, indicating that even subtle, undetected internal bleeding can contribute to anemia9 . Ferritin levels below 45 µg/L were more prevalent in the aspirin group, reflecting iron deficiency4 .
- Aspirin inhibits platelet aggregation, reducing blood clotting and increasing bleeding risk5 .
- It disrupts protective prostaglandins in the GI mucosa, leading to mucosal injury and bleeding4 .
- Chronic low-grade GI bleeding causes iron loss, leading to iron deficiency anemia3 .
- Declining hemoglobin and ferritin levels over time indicate ongoing blood loss8 9.
- Anemia in older adults is associated with functional decline, fatigue, disabilities, depressive symptoms, and cognitive problems2 19.
- Regular monitoring of hemoglobin and ferritin levels is advisable for older adults on long-term low-dose aspirin1 9.
- Patients should be evaluated for anemia symptoms such as weakness, shortness of breath, and dizziness1 .
| Study/Population | Anemia Incidence (Aspirin) | Anemia Incidence (Placebo/Non-users) | Notes |
|---|---|---|---|
| ASPREE Trial6 | Increased (HR 1.20) | Reference | Median follow-up 4.7 years |
| Danish Cohort8 | 5.9% | Lower (IRR 7.89) | Severe anemia 1.3% vs. 0.6% |
Daily low-dose aspirin can help prevent heart attacks but comes with an increased risk of bleeding. Older adults taking aspirin are about 20% more likely to develop anemia, often due to subtle internal bleeding. Monitoring blood counts annually is recommended for those on aspirin therapy10 1.
Heart Attack Prevention Alternatives
While low-dose aspirin has been widely used for primary prevention of cardiovascular disease, its benefits must be weighed against the increased risk of bleeding and anemia, especially in older adults without existing cardiovascular disease6 10. Current guidelines recommend aspirin primarily for people with coronary artery disease (CAD) or other vascular diseases and for those under 70 years at high risk of heart attack10 .
- Clopidogrel: A blood thinner more effective than aspirin in preventing heart attacks and strokes, with a 14% lower risk of major cardiovascular events and similar bleeding risk11 .
- Lifestyle modifications: Healthy diet, regular exercise, smoking cessation, and blood pressure control remain foundational for heart attack prevention12 .
- Other blood thinners: Medications like rivaroxaban, ticagrelor, and prasugrel are options but carry bleeding risks and require medical supervision12 .
- Periodic monitoring: For those on aspirin, regular blood tests to check hemoglobin and iron status can help detect anemia early1 9.
- The risk of bleeding from aspirin increases with age, making routine use for primary prevention in adults aged 70 and older generally not recommended10 .
- Aspirin doses as low as 10 mg daily can cause gastric ulcers, and proton pump inhibitors (PPIs) only partially protect against GI bleeding4 .
- Combining aspirin with other blood thinners significantly raises bleeding risk5 .
- Personalized assessment of cardiovascular risk versus bleeding risk is essential before starting aspirin10 .
